Acta Pharma Reports ISSN 3041-5381 is a biannually peer-reviewed multi-disciplinary pharmaceutical publication to serve as a means for scientific information exchange in the international pharmaceutical forum. It accepts novel findings that contribute to advancement of scientific knowledge in pharmaceutical fields that not been published or under consideration for publication anywhere else for publication in JRPS as original research article and all aspects of pharmaceutical sciences consisting of medicinal chemistry, molecular modeling, drug design, pharmaceutics, bio-pharmacy, pharmaceutical nanotechnology, pharmacognosy, natural products, pharmaceutical biotechnology, pharmacology, toxicology and clinical pharmacy.
The journal is registered with the following abstracting partners:
American Society of Health System Pharmacists, Baidu Scholar, Previews, CNKI (China National Knowledge Infrastructure Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang Data
Submit Proposal
Acta Pharma Reports [ISSN 3041-5381] runs special issues to create collections of papers on specific topics. The aim is to build a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors who are experts in the subject and oversee the editorial process for papers. Papers published in a Special Issue will be collected together on a dedicated page of the journal website. For any inquiries related to a Special Issue, please contact the Editorial desk at editor@pharma.researchfloor.org or submission@pharma.researchfloor.org
Acta Pharma Reports
[ISSN: 3041-5381 (Online)]
Frequency 2 issues per year
Language-English
Subject: Pharmaceutical Sciences
Starting Year 2022
Format of publication –Online
Country of Publication-Belgium
Discover the Latest in Pharmaceutical Sciences with the Journal of Acta Pharma Reports. Explore Groundbreaking Research, Innovation, and Insights. Stay Ahead in Pharma’s Dynamic Landscape.
Introduction Deep vein thrombosis (DVT) is a major component of venous thromboembolism (VTE), which remains a major cause of cardiovascular morbidity and mortality worldwide. For a long time, oral anticoagulation
1. Introduction The effectiveness of drug therapy varies substantially among individuals due to differences in genetic makeup, environmental exposures, lifestyle factors, age, sex, and disease characteristics. Conventional therapeutic approaches typically
1. Introduction N- (Substituted Aryl) Acryloyl Theophylline Derivatives are a class of compounds that involve the combination of theophylline, a known methylxanthine derivative, with acryloyl groups and substituted aryl groups.
1. INTRODUCTION Reflexology occupies a unique position in the landscape of complementary and alternative medicine (CAM), combining elements of manual therapy, neurophysiological theory, and ancient healing traditions. In modern clinical
INTRODUCTION: The term hypothyroidism is derived from the Greek words hypo- meaning “reduced,” thyreos meaning “defence,” and eidos meaning “form.” Primary hypothyroidism refers to hormonal inadequacy caused by intrinsic thyroid
Introduction The verifiable evolution of drug delivery systems highlights the progression from simple formulations to sophisticated, technology-driven approaches. Sustained release preparations offer numerous advantages over the conventional forms. The main
Introduction The term cosmeceutical was coined by Dr. Albert Kligman in 1984 to describe a hybrid category of products that bridge the gap between cosmetics and pharmaceuticals. These products contain
INTRODUCTION Eucalyptus globulus, a tree species widely recognised for its broad spectrum of pharmacological properties, has been the focus of numerous studies exploring its potential health-promoting effects [1]. Eucalyptus globulus
INTRODUCTION“The Emergency Use Authorisation (EUA)” framework was established in 2004 during “The Project Bioshield Act 2004”, in the “Federal Food, Drug and Cosmetic Act”, to ratify the use of specific
